Natural products inducing nucleolar stress: implications in cancer therapy

Anticancer Drugs. 2022 Jan 1;33(1):e21-e27. doi: 10.1097/CAD.0000000000001146.

Abstract

The nucleolus is the site of ribosome biogenesis and is found to play an important role in stress sensing. For over 100 years, the increase in the size and number of nucleoli has been considered as a marker of aggressive tumors. Despite this, the contribution of the nucleolus and the biologic processes mediated by it to cancer pathogenesis has been largely overlooked. This state has been changed over the recent decades with the demonstration that the nucleolus controls numerous cellular functions associated with cancer development. Induction of nucleolar stress has recently been regarded as being superior to conventional cytotoxic/cytostatic strategy in that it is more selective to neoplastic cells while sparing normal cells. Natural products represent an excellent source of bioactive molecules and some of them have been found to be able to induce nucleolar stress. The demonstration of these nucleolar stress-inducing natural products has paved the way for a new therapeutic approach to more delicate tumor cell-killing. This review provides a contemporary summary of the role of the nucleolus as a novel promising target for cancer therapy, with particular emphasis on natural products as an exciting new class of anti-cancer drugs with nucleolar stress-inducing properties.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Biological Products / pharmacology*
  • Cell Nucleolus / drug effects*
  • DNA, Ribosomal / drug effects
  • Humans
  • Neoplasms / drug therapy
  • Neoplasms / pathology*
  • RNA Polymerase I / drug effects
  • RNA, Ribosomal / drug effects
  • Stress, Physiological / drug effects

Substances

  • Antineoplastic Agents
  • Biological Products
  • DNA, Ribosomal
  • RNA, Ribosomal
  • RNA Polymerase I